Volume 272, Number 23,
Issue of June 6, 1997
pp. 14666-14671
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Suppression of Substance P Biosynthesis in Sensory Neurons of
Dorsal Root Ganglion by Prodrug Esters of Potent Peptidylglycine
-Amidating Monooxygenase Inhibitors
(Received for publication, September 16, 1996, and in revised form, March 31, 1997)
Arco Y.
Jeng
,
Roger A.
Fujimoto
,
Mary
Chou
,
Jenny
Tan
and
Mark D.
Erion
From the Research Department, Novartis Pharmaceuticals Corp.,
Summit, New Jersey 07901
Substance P as well as many other neuropeptides
are synthesized as glycine-extended precursors and converted to the
biologically active C-terminal amides by posttranslational
modification. The final step of posttranslational processing is
catalyzed by peptidylglycine
-amidating monooxygenase (PAM). In a
previous study, N-substituted homocysteine analogs were
found to be potent inhibitors of PAM partially purified from
conditioned medium of cultured rat medullary thyroid carcinoma CA-77
cells. These compounds, however, were only modest inhibitors of
substance P production in cultured dorsal root ganglion cells, possibly
because of poor cell penetration. Several ester derivatives of
hydrocinnamoyl-phenylalanyl-homocysteine, one of the most potent
PAM inhibitors, were prepared to increase the intracellular
accessibility of these compounds.
Hydrocinnamoyl-phenylalanyl-(S-benzoyl-homocysteine) benzyl
ester was identified as the most potent compound, inhibiting substance
P biosynthesis in dorsal root ganglion cells with an IC50
of 2 µM. Inhibition of PAM resulted in a concomitant
increase in the glycine-extended substance p (substance P-Gly)
precursor peptide. In the presence of 3 µM benzyl ester
derivative, the intracellular substance P-Gly level was 2.4-fold higher
while the substance P level was 2.1-fold lower than the corresponding peptides in control cells. These results suggest that PAM inhibition represents an effective method for suppression of substance P biosynthesis and, therefore, may have therapeutic utility in conditions associated with elevated substance P levels. Furthermore, PAM inhibition may also prove useful in decreasing other amidated peptides.